N@N

Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.

^{Published on 2011-10-03 17:22:05 - Market Wire}
 

WILMINGTON, Del.--([ BUSINESS WIRE ])--[ Rigrodsky & Long, P.A. ] announces that it is investigating potential claims against the board of directors of Pharmaceutical Product Development, Inc. (aPPDa or the aCompanya) (Nasdaq: [ PPDI ]) concerning possible breaches of fiduciary duty and other violations of law related to the Companya™s entry into an agreement to be acquired and be taken private by The Carlyle Group and Hellman & Friedman in a transaction with an approximate value of $3.9 billion.

Click here to learn more and how to join the action: [ http://investigations.rigrodskylong.com/pharmaceuticalproductdevelopmentinc-ppdi/ ].

Under the proposed agreement, PPD shareholders will receive $33.25 per share in cash for every share of PPD common stock they own.

The investigation concerns whether PPDa™s board of directors adequately shopped the Company to obtain the best price possible for PPDa™s shareholders before entering into the agreement with The Carlyle Group and Hellman & Friedman. Indeed, according to Yahoo! Finance, at least one analyst has set a $38.00 per share price target for PPD stock.

If you own the common stock of PPD and purchased your shares before October 3, 2011, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact [ Seth D. Rigrodsky, Esquire ] or [ Noah R. Wortman, Case Development Director ], of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or by e-mail to [ info@rigrodskylong.com ].

[ Rigrodsky & Long, P.A. ], with offices in Wilmington, Delaware and Garden City, New York, regularly litigates [ securities class, derivative and direct actions, shareholder rights litigation ] and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.